Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial

Heart, Artery and Coronary DiseasesMyocardial Infarction

Complete versus culprit lesion-only revascularisation for acute myocardial infarction (Complete Revascularisation Trialists' Collaboration): an individual patient data meta-analysis of randomised trials

Lancet

Mehta SR, Tiong DTW, Böhm F, Ramasundarahettige C, Biscaglia S, Campo G, James S, Smits PC, Giacoppo D, McCann GP, Banning A, Høfsten DE, Casella G, Kirabo FR, Nguyen H, Wood DA, Cairns JA, Engstrøm T

doi: 10.1016/S0140-6736(25)02170-1

Myocardial Infarction

Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention

Clin Res Cardiol

Jakob P, Varbella F, Linke A, Schwarz B, Felix SB, Seiffert M, Kesterke R, Nordbeck P, Witzenbichler B, Lang IM, Kessler M, Valina C, Dibra A, Rohla M, Moccetti M, Vercellino M, Gaede L, Bott-Flügel L, Stehli J, Candreva A, Paneni F, Templin C, Schindler M, Wischnewsky M, Zanda G, Quadri G, Mangner N, Toma A, Magnani G, Clemmensen P, Lüscher TF, Münzel T, Schulze PC, Laugwitz KL, Rottbauer W, Huber K, Neumann FJ, Schneider S, Riemer T, Weidinger F, Achenbach S, Richardt G, Kastrati A, Ford I, Ruschitzka F, Stähli BE, MULTISTARS A. M. I. Investigators

doi: 10.1007/s00392-025-02745-x

Further Publications

Sex Differences Among Young Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis

J Am Heart Assoc

Pugliesi GM, Onyeji P, Verolino G, MomplaisirOnyeji S, Fazzini L, Łajczak P, Toukam MSM, Sala D, Quartieri EA, Lenzi MC, Perego GB, Calderone D

doi: 10.1161/JAHA.125.046648

Myocardial Infarction

Anatomical, physiological and inflammatory characterization of non-culprit vessels in patients undergoing primary PCI for ST-elevation myocardial infarction in the presence of multivessel disease: Rationale and design of the PICNIC study

Am Heart J

Mahmoudi M, Nicholas Z, Jabbour RJ, Shambrook J, Abbas A, Browne T, Hinton J, Antoniades C, Mamas M, Leipsic J, Rogers C, Koo BK, Al-Lamee R, Kontopantelis E, Curzen N

doi: 10.1016/j.ahj.2025.107298

Myocardial InfarctionFurther Publications

Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction: Three-Year Outcomes of a Randomized Clinical Trial

JAMA Cardiol

Biscaglia S, Erriquez A, Guiducci V, Escaned J, Moreno R, Lanzilotti V, Santarelli A, Cerrato E, Sacchetta G, Menozzi A, Amat-Santos I, Díez Gil JL, Ruozzi M, Barbierato M, Fileti L, Picchi A, Pavasini R, Cimaglia P, Colaiori I, Casella G, Menozzi M, Cavazza C, Caretta G, Scarsini R, D'Amico G, Vadalà G, Pilato G, Moscarella E, Tebaldi M, Campo G

doi: 10.1001/jamacardio.2025.3099

Myocardial Infarction

Mineralocorticoid Receptor Antagonists in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Trials

JACC Heart Fail

d'Entremont MA, Cheema Z, Pitt B, Kedev S, Cornel JH, Stankovic G, Moreno R, Storey R, Bossard M, Chauhan A, Montalescot G, Beygui F, Zannad F, Jolly S, Mineralocorticoid Antagonist Post Myocardial Infarction Trialist Collaboration

doi: 10.1016/j.jchf.2025.102531

Myocardial InfarctionTherapy and Intervention

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Circulation

Thrane PG, Maeng M, Maehara A, Bøtker HE, Mintz GS, Kjøller-Hansen L, Engstrøm T, Matsumura M, Kotinkaduwa LN, Fröbert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie Ø, Held C, James SK, Ali ZA, Erlinge D, Stone GW

doi: 10.1161/CIRCULATIONAHA.124.071980

Heart, Artery and Coronary DiseasesMyocardial Infarction

Impact of Coronary Artery Disease Extent on GRACE Risk Score Prognostic Performance After ST-Segment-Elevation Myocardial Infarction

J Am Heart Assoc

Kuku KO, Lenselink C, Venema CS, Garcia-Garcia HM, van der Harst P, Lipsic E, Voors AA, Wykrzykowska JJ

doi: 10.1161/JAHA.125.047124

Myocardial Infarction

Selective C-reactive protein apheresis in ST-elevation myocardial infarction: Design and rationale of the randomized CRP-STEMI trial

Am Heart J

Reinstadler SJ, Kronbichler A, Reindl M, Tiller C, Holzknecht M, Oberhollenzer F, Kaser A, Gauckler P, Stiermaier T, Feistritzer HJ, Mayr A, Gizewski ER, Rezar R, Bugger H, Eller K, Eitel I, Schneider S, Mayer G, Thiele H, Bauer A, Metzler B, Lechner I, CRP-STEMI Investigators

doi: 10.1016/j.ahj.2025.07.067

Related content

Complete versus culprit lesion-only revascularisation for acute myocardial infarction (Complete Revascularisation Trialists' Collaboration): an individual patient data meta-analysis of randomised trials

Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention

Sex Differences Among Young Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis

Anatomical, physiological and inflammatory characterization of non-culprit vessels in patients undergoing primary PCI for ST-elevation myocardial infarction in the presence of multivessel disease: Rationale and design of the PICNIC study

Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction: Three-Year Outcomes of a Randomized Clinical Trial

Mineralocorticoid Receptor Antagonists in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Trials

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Impact of Coronary Artery Disease Extent on GRACE Risk Score Prognostic Performance After ST-Segment-Elevation Myocardial Infarction

Selective C-reactive protein apheresis in ST-elevation myocardial infarction: Design and rationale of the randomized CRP-STEMI trial